Seres therapeutics to host virtual investor event on june 21, 2021

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb) today announced that it will host a virtual investor event focused on ser-287 and ser-301, potential new therapeutic options for ulcerative colitis (uc) on monday, june 21, 2021 from 8:30 a.m. to 10:00 a.m. et. during the event, seres' management and stephen hanauer, m.d., professor of medicine at northwestern university feinberg school of medicine will discuss the uc patient burden, the need for new therapeutic approach
MCRB Ratings Summary
MCRB Quant Ranking